Dalfampridine in the treatment of multiple sclerosis: a meta-analysis of randomised controlled trials.

Enyao ZhangXin TianRuoming LiChaoyang ChenMin LiLingyun MaRan WeiYing ZhouYi Min Cui

Published in: Orphanet journal of rare diseases (2021)

Dalfampridine exerts positive effects on walking ability, finger dexterity, and cognitive function. Treatment should be administered under the guidance of a physician or pharmacist given the higher incidence of adverse events.

Keyphrases

multiple sclerosis
emergency department
primary care
risk factors
smoking cessation